Literature DB >> 28715204

A Prodomain Fragment from the Proteolytic Activation of Growth Differentiation Factor 11 Remains Associated with the Mature Growth Factor and Keeps It Soluble.

Blake Pepinsky1, Bang-Jian Gong1, Yan Gao1, Andreas Lehmann1, Janine Ferrant1, Joseph Amatucci1, Yaping Sun1, Martin Bush2, Thomas Walz2, Nels Pederson1, Thomas Cameron1, Dingyi Wen1.   

Abstract

Growth differentiation factor 11 (GDF11), a member of the transforming growth factor β (TGF-β) family, plays diverse roles in mammalian development. It is synthesized as a large, inactive precursor protein containing a prodomain, pro-GDF11, and exists as a homodimer. Activation requires two proteolytic processing steps that release the prodomains and transform latent pro-GDF11 into active mature GDF11. In studying proteolytic activation in vitro, we discovered that a 6-kDa prodomain peptide containing residues 60-114, PDP60-114, remained associated with the mature growth factor. Whereas the full-length prodomain of GDF11 is a functional antagonist, PDP60-114 had no impact on activity. The specific activity of the GDF11/PDP60-114 complex (EC50 = 1 nM) in a SMAD2/3 reporter assay was identical to that of mature GDF11 alone. PDP60-114 improved the solubility of mature GDF11 at neutral pH. As the growth factor normally aggregates/precipitates at neutral pH, PDP60-114 can be used as a solubility-enhancing formulation. Expression of two engineered constructs with PDP60-114 genetically fused to the mature domain of GDF11 through a 2x or 3x G4S linker produced soluble monomeric products that could be dimerized through redox reactions. The construct with a 3x G4S linker retained 10% activity (EC50 = 10 nM), whereas the construct connected with a 2x G4S linker could only be activated (EC50 = 2 nM) by protease treatment. Complex formation with PDP60-114 represents a new strategy for stabilizing GDF11 in an active state that may translate to other members of the TGF-β family that form latent pro/mature domain complexes.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28715204     DOI: 10.1021/acs.biochem.7b00302

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  Structure of the human myostatin precursor and determinants of growth factor latency.

Authors:  Thomas R Cotton; Gerhard Fischer; Xuelu Wang; Jason C McCoy; Magdalena Czepnik; Thomas B Thompson; Marko Hyvönen
Journal:  EMBO J       Date:  2018-01-12       Impact factor: 11.598

2.  Tolloid cleavage activates latent GDF8 by priming the pro-complex for dissociation.

Authors:  Viet Q Le; Roxana E Iacob; Yuan Tian; William McConaughy; Justin Jackson; Yang Su; Bo Zhao; John R Engen; Michelle Pirruccello-Straub; Timothy A Springer
Journal:  EMBO J       Date:  2018-01-17       Impact factor: 11.598

3.  Investigation on the processing and improving the cleavage efficiency of furin cleavage sites in Pichia pastoris.

Authors:  Yide Huang; Yanyu Long; Suhuan Li; Ting Lin; Jingwen Wu; Yafei Zhang; Yao Lin
Journal:  Microb Cell Fact       Date:  2018-11-08       Impact factor: 5.328

4.  The anti-Müllerian hormone prodomain is displaced from the hormone/prodomain complex upon bivalent binding to the hormone receptor.

Authors:  Richard L Cate; Nathalie di Clemente; Chrystèle Racine; Nigel P Groome; R Blake Pepinsky; Adrian Whitty
Journal:  J Biol Chem       Date:  2021-11-19       Impact factor: 5.157

5.  GDF11 induces differentiation and apoptosis and inhibits migration of C17.2 neural stem cells via modulating MAPK signaling pathway.

Authors:  Zongkui Wang; Miaomiao Dou; Fengjuan Liu; Peng Jiang; Shengliang Ye; Li Ma; Haijun Cao; Xi Du; Pan Sun; Na Su; Fangzhao Lin; Rong Zhang; Changqing Li
Journal:  PeerJ       Date:  2018-09-04       Impact factor: 2.984

6.  Endogenous GDF11 regulates odontogenic differentiation of dental pulp stem cells.

Authors:  Xingying Qi; Qingyue Xiao; Rui Sheng; Shuang Jiang; Quan Yuan; Weiqing Liu
Journal:  J Cell Mol Med       Date:  2020-08-26       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.